Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial (EPI Dose)

NCT05327556 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT05327556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05327556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial (EPI Dose)
Lead sponsor
Boston Children's Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 8, 2023
Completion date
May 16, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension